MetaCap

Warby Parker Inc. Class A (WRBY)

NYSE: WRBYHealth CareOphthalmic GoodsUSD

23.12-1.01 (-4.19%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

WRBY stock chart

Technical analysis

Key statistics

All statistics
P/E (TTM)
385.33
52-week range
17.83 – 31.75
Day range
22.91 – 24.50
Volume / Avg
7.17M / 3.64M
Beta
—

52-week range

$17.83$31.75

WRBY stock today

Warby Parker (WRBY) closed at $23.12 on Nov 20, down 4.19% (-$1.01), versus the S&P 500's 3.70% decline. At this level, WRBY sits in the middle of its 52-week range of $17.83 to $31.75: 27.2% below the high, set on Nov 11, 2026 and 29.7% above the low. WRBY is up 6.1% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 26.5%.

At 385.3x trailing earnings, Warby Parker trades above the peer-group median of 20.4x. Its forward P/E of 36.4x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About Warby Parker

Company profile

Warby Parker Inc. sells eyewear products through its retail and e-commerce platform in the United States and Canada. The company offers eyeglasses and sunglasses; and single-vision, progressive, light-responsive, polarized, blue-light-filtering, tinted, non-prescription, and contact lenses.

Industry
Ophthalmic Goods
CEO
Mr. Neil Harris Blumenthal
Headquarters
New York, NY
Employees
2,275
IPO year
2021

Financial highlights

Full financials

In fiscal 2025, Warby Parker generated $871.9 million in revenue, up 13.0% from fiscal 2024, its 6th consecutive year of revenue growth. Net income was $1.6 million, for a net margin of 0.2% versus a median of -14.2% in the prior 5 years. Gross margin was 54.0% (down from 55.3%) and operating margin -0.6%.

Warby Parker annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$871.90M$771.32M$669.76M$598.11M$540.80M
Growth+13.04%+15.16%+11.98%+10.60%+37.36%
Net income$1.64M$-20.39M$-63.20M$-110.39M$-144.27M
EPS (diluted)$0.01$-0.17$-0.54$-0.96$-2.21

Analyst forecast

Forecast

Consensus (13 analysts)

buy

Avg. price target

$32.25+39.49%

  • Strong buy 2
  • Buy 8
  • Hold 3
  • Sell 0
  • Strong sell 0

Target range

Low $25.00High $40.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 5, 2026
EPS actual vs est.
$0.04 vs $0.03
Surprise
+33.33%

WRBY news

All WRBY news

Warby Parker peers

Health Care sector
WRBY peer companies
CompanyPrice% ChgMarket capCompare
EYENational Vision Holdings Inc.16.72-1.70%$1.31Bvs WRBY
STAASTAAR Surgical Company24.22-3.24%$1.22Bvs WRBY
RXSTRxSight Inc.4.47-3.04%$187.42Mvs WRBY
LUCYInnovative Eyewear Inc.0.7025-0.07%$6.12Mvs WRBY
BLCOBausch + Lomb Corporation19.38-6.33%$6.93Bvs WRBY
COOThe Cooper Companies Inc.58.88-2.40%$11.20Bvs WRBY
ALCAlcon Inc.74.31-0.26%$35.70Bvs WRBY

Indexes, lists and sector

Warby Parker stock FAQ

What is Warby Parker's stock price today?

WRBY last traded at $23.12 as of Nov 20, 4:00 PM EST, down 4.19% on the day. Prices are delayed at least 15 minutes.

What is WRBY's P/E ratio?

WRBY trades at a trailing P/E ratio of 385.33 and a forward P/E of 36.44, compared with a median of 20.4 for its closest peers.

Who is Warby Parker's CEO?

Mr. Neil Harris Blumenthal is the chief executive officer of Warby Parker Inc. Class A, which has about 2,275 employees.

What is the WRBY 52-week high?

The 52-week high for WRBY is $31.75 and the 52-week low is $17.83. The stock is currently 27.2% below its high.

Compare WRBY